ETCapital | Press Releases

Radcliffe Camera and historic university buildings in Oxford, England, viewed from above on a clear day.

Press Releases

Bango (AIM:BGO) announced the acquisition of Docomo Digital - the global payments business of NTT DOCOMO - bringing an additional $3.5B of end user spend from c.2 billion users worldwide.

September 2022 Press Release

FDA approves first ADC Therapeutics anti-cancer drug, ZYNLONTA™, for clinical use in patients with relapsed or refractory diffuse large B-Cell Lymphoma.

August 2021 Press Release

Phico Therapeutics awarded up to $18.2 million (c.£13.2 million) CARB-X funding to advance SASPject antibacterial therapy through Phase 1 clinical trials.

April 2021 Press Release

ADC Therapeutics SA, the innovative anti-cancer therapeutics business, has floated on the New York Stock Exchange. Demand for the issue was high with an upsized placing and shares trading at an immediate premium.

May 2020 Press Release

ADC Therapuetics announces positive results from pivotal Phase 2 clinical trial of its lead therapeutic.

January 2020 Press Release

ET Capital is appointed manager of UK China Enterprise a fund exploiting the potential of UK innovation and technology driven business to scale-up in China.

February 2018 Press Release

ADC Therapeutics raises $200 Million in private placing to fund registrational trials of its lead anti-cancer drugs.

October 2017 Press Release

Phico Therapeutics raises £3.5M in its fight against antibiotic resistant superbugs.

November 2016 Press Release